Tech Exchange with BIOEMTECH

In our last Tech Exchange episode in 2025 we will hear from BIOEMTECH about their preclinical imaging solutions.

Elina Stamatelatou will talk about "Preclinical Metabolic PET with β-eye^ΤΜ: Case Studies and Results".

Abstract:

This presentation shows the capabilities of the β-eye™ preclinical PET system for metabolic imaging, highlighting its suitability for whole-body studies. Through a series of case studies, including tumor metabolism with [¹⁸F]FDG, skeletal imaging with [¹⁸F]NaF, cardiac metabolism in myocardial infarction models, and advanced in-ovo imaging, it is demonstrated how real-time PET enables quantitative assessment of disease mechanisms, therapy response, and radiotracer pharmacokinetics. The results highlight the value of metabolic PET as a powerful, non-invasive tool that supports translational research, and accelerates preclinical drug development.